Evidence map›Paper›PMID 27230443›Full record

ArticleThe European respiratory journal2016

Digital health for the End TB Strategy: developing priority products and making them work.

Dennis Falzon, Hazim Timimi, Pascal Kurosinski, Giovanni Battista Migliori, Wayne Van Gemert, Claudia Denkinger, Chris Isaacs, Alistair Story, Richard S Garfein, Luis Gustavo do Valle Bastos and 14 more

Abstract read
In one paragraph

Article in The European respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2019
    Guideline
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Dennis FalzonGlobal TB Programme, World Health Organization, Geneva, Switzerland falzond@who.int.
Hazim TimimiGlobal TB Programme, World Health Organization, Geneva, Switzerland.
Pascal KurosinskiEuropean Respiratory Society, Lausanne, Switzerland.
Giovanni Battista MiglioriEuropean Respiratory Society, Lausanne, Switzerland WHO Collaborating Centre, Fondazione S. Maugeri, Tradate, Italy.
Wayne Van GemertGlobal TB Programme, World Health Organization, Geneva, Switzerland.
Claudia DenkingerFIND, Geneva, Switzerland.
Chris IsaacsFIND, Geneva, Switzerland.
Alistair StoryFind & Treat, University College London Hospitals, London, UK.
Richard S GarfeinUniversity of California San Diego School of Medicine, La Jolla, CA, USA.
Luis Gustavo do Valle BastosManagement Sciences for Health, Arlington, VA, USA.
Mohammed A YassinThe Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland.
Valiantsin RusovichWHO Country Office, Minsk, Belarus.
Alena SkrahinaRepublican Scientific and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus.
Le Van HoiNational TB Programme, Hanoi, Viet Nam.
Tobias BrogerFIND, Geneva, Switzerland.
Ibrahim AbubakarUniversity College London, London, UK.
Andrew HaywardFarr Institute of Health Informatics, University College London, London, UK.
Bruce V ThomasThe Arcady Group, Richmond, VA, USA.
Zelalem TemesgenMayo Clinic, Rochester, MN, USA.
Subhi QuraishiZMQ, New Delhi, India.
Dalene von DelftTB Proof, Cape Town, South Africa.
Ernesto JaramilloGlobal TB Programme, World Health Organization, Geneva, Switzerland.
Karin WeyerGlobal TB Programme, World Health Organization, Geneva, Switzerland.
Mario C RaviglioneGlobal TB Programme, World Health Organization, Geneva, Switzerland.

Funding

Medical Research Council MR/K006584/1
6 · The paper itself

Abstract

In 2014, the World Health Organization (WHO) developed the End TB Strategy in response to a World Health Assembly Resolution requesting Member States to end the worldwide epidemic of tuberculosis (TB) by 2035. For the strategy's objectives to be realised, the next 20 years will need novel solutions to address the challenges posed by TB to health professionals, and to affected people and communities. Information and communication technology presents opportunities for innovative approaches to support TB efforts in patient care, surveillance, programme management and electronic learning. The effective application of digital health products at a large scale and their continued development need the engagement of TB patients and their caregivers, innovators, funders, policy-makers, advocacy groups, and affected communities.In April 2015, WHO established its Global Task Force on Digital Health for TB to advocate and support the development of digital health innovations in global efforts to improve TB care and prevention. We outline the group's approach to stewarding this process in alignment with the three pillars of the End TB Strategy. The supplementary material of this article includes target product profiles, as developed by early 2016, defining nine priority digital health concepts and products that are strategically positioned to enhance TB action at the country level.

Indexed as

Electronic Health RecordsHealth PrioritiesTelemedicineWorld Health OrganizationAdvisory CommitteesCommunicable Disease ControlEpidemicsForecastingHealth Services AccessibilityHumansTuberculosis

Identifiers

PMID27230443
PMCPMC4929075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.